What is CNY Neurodiagnostics?
Established in 2014 by Dr. Samah O. Mohiuddin MD, CNY Neurodiagnostics PLLC operates as a specialized private neurology practice dedicated to the comprehensive management of intricate nervous system disorders. The firm provides critical diagnostic and therapeutic services for a wide spectrum of conditions, including stroke, dementia, Parkinson's disease, epilepsy, and various spine, nerve, and muscle pathologies. By bridging the gap between advanced clinical research and patient-centric care, the practice serves as a vital resource for both the local community and referring physicians seeking expert intervention for complex cases. Their market position is defined by a commitment to high-acuity care, integrating diagnostic precision with long-term management strategies for chronic conditions such as sleep disorders and persistent headaches.
How much funding has CNY Neurodiagnostics raised?
CNY Neurodiagnostics has raised a total of $39K across 1 funding round:
Debt
$39K
Debt (2021): $39K with participation from PPP
Key Investors in CNY Neurodiagnostics
PPP
Public-Private Partnership
What's next for CNY Neurodiagnostics?
Looking ahead, the strategic deployment of this capital will likely focus on infrastructure modernization and the integration of advanced diagnostic technologies to improve patient throughput and clinical accuracy. As the practice moves through this growth phase, the focus will remain on expanding its referral network and potentially increasing its footprint in the regional healthcare ecosystem. By optimizing its operational framework, CNY Neurodiagnostics aims to set a new standard for neurological care, ensuring that the practice remains at the forefront of medical innovation while maintaining the personalized attention that defines its service model. Future growth will be measured by the firm's ability to scale its specialized offerings without compromising the quality of care that has become its hallmark.
See full CNY Neurodiagnostics company page
